Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus
- 1 February 1999
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 43 (3) , 517-523
- https://doi.org/10.1016/s0360-3016(98)00463-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the EsophagusNew England Journal of Medicine, 1997
- A phase study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): Preliminary toxicity reportInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.Journal of Clinical Oncology, 1997
- A Comparison of Multimodal Therapy and Surgery for Esophageal AdenocarcinomaNew England Journal of Medicine, 1996
- Combined intensive chemoradiotherapy for organ preservation in patients with resectable and non-resectable oesophageal cancerEuropean Journal Of Cancer, 1996
- A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagusCancer, 1994
- Neoadjuvant chemotherapy and radiotherapy in locally advanced esophagus carcinoma: Long-term resultsInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusNew England Journal of Medicine, 1992